Marimed (MRMD) Current Assets (2011 - 2026)
Marimed (MRMD) posted quarterly Current Assets of $60.8 million for Q1 2026, up 4.8% year-over-year from $58.0 million in Q1 2025, and up 2.53% quarter-over-quarter from $59.3 million in Q4 2025.
Marimed (MRMD) Current Assets (2011 - 2026) Analysis & Trends
Marimed (MRMD) has reported Current Assets for 16 consecutive years, with $60.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 4.8% year-over-year to $60.8 million; the TTM figure through Mar 2026 stood at $60.8 million (up 4.8% YoY), while the FY2025 annual figure was $59.3 million, up 10.8% from the prior year.
- Current Assets rose to $60.8 million in Q1 2026 per MRMD's latest filing, from $59.3 million in the prior quarter.
- Across five years, Current Assets topped out at $60.8 million in Q1 2026 and bottomed at $33.6 million in Q2 2022.
- Historically, Current Assets has averaged $53.3 million across 5 years, with a median of $54.9 million in 2024.
- Annual changes were most pronounced in 2022 — Current Assets slipped 17.88% — and 2023, when it soared 72.63%.
- Marimed's Current Assets stood at $44.1 million in 2022, then advanced by 16.5% to $51.4 million in 2023, then advanced by 4.04% to $53.5 million in 2024, then climbed by 10.8% to $59.3 million in 2025, then increased by 2.53% to $60.8 million in 2026.
- Business Quant data shows MRMD's Current Assets at $60.8 million in Q1 2026, $59.3 million in Q4 2025, and $60.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Marimed | 27.77 Mn | 19.33 Mn | 16.23 Mn | 58.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.43 Mn |
| Mar 31, 2026 | 60.79 Mn |
| Dec 31, 2025 | 59.29 Mn |
| Sep 30, 2025 | 60.09 Mn |
| Jun 30, 2025 | 57.13 Mn |
| Mar 31, 2025 | 58.00 Mn |
| Dec 31, 2024 | 53.51 Mn |
| Sep 30, 2024 | 56.68 Mn |
| Jun 30, 2024 | 53.05 Mn |
| Mar 31, 2024 | 54.90 Mn |
| Dec 31, 2023 | 51.43 Mn |
| Sep 30, 2023 | 50.79 Mn |
| Jun 30, 2023 | 57.92 Mn |
| Mar 31, 2023 | 59.37 Mn |
| Dec 31, 2022 | 44.15 Mn |
| Sep 30, 2022 | 40.88 Mn |
| Jun 30, 2022 | 33.55 Mn |
| Mar 31, 2022 | 54.31 Mn |
| Dec 31, 2021 | 44.61 Mn |
| Sep 30, 2021 | 49.79 Mn |